Search
Fenclofenac
go.drugbank.com/drugs/DB21391ExperimentalFenclofenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Fenclofenac is a anti-inflammatory agent, ibufenac derivative.
Pirinidazole
go.drugbank.com/drugs/DB21413ExperimentalPirinidazole is a small molecule drug. The usage of the INN stem '-nidazole' in the name indicates that Pirinidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.
Tifurac
go.drugbank.com/drugs/DB21415ExperimentalTifurac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Tifurac is a anti-inflammatory agent, ibufenac derivative.
Canocapavir
go.drugbank.com/drugs/DB21570ExperimentalCanocapavir is a small molecule drug. The usage of the INN stem '-capavir' in the name indicates that Canocapavir is a viral capsid and nucleocapsid inhibitor.
Emzeltrectinib
go.drugbank.com/drugs/DB21605ExperimentalEmzeltrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Emzeltrectinib is a tropomyosin receptor kinase (TRK) inhibitor.
Zavondemstat
go.drugbank.com/drugs/DB21608ExperimentalZavondemstat is a small molecule drug. The usage of the INN stem '-demstat' in the name indicates that Zavondemstat is a Lysine-specific histone demethylase inhibitor.
AVI-7537
go.drugbank.com/drugs/DB15433Investigational[L46207] AVI-7537 is under investigation in clinical trial NCT01593072 (A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers). … AVI-7537 is an antisense molecule that binds to the Ebola virus mRNA to prevent the viral replication.
Phosphoaminophosphonic acid guanylate ester
go.drugbank.com/drugs/DB02082ExperimentalA non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. … The nucleotide is a potent stimulator of adenylate cyclase.
(1R,2S)-2-Phenylcyclopropanaminium
go.drugbank.com/drugs/DB02665ExperimentalThis monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders.
Surzebiclimab
go.drugbank.com/drugs/DB16669InvestigationalSurzebiclimab is under investigation in clinical trial NCT03744468 (Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid Tumors).